| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 08/16/2007 | US20070190160 Nanoparticles for drug-delivery |
| 08/16/2007 | US20070190132 Pharmaceutical compositions for oral and topical administration |
| 08/16/2007 | US20070190022 Combination methods of treating cancer |
| 08/16/2007 | US20070190019 Compositions and methods for topical administration |
| 08/16/2007 | US20070189981 Porphorymonas gingivalis polypeptides and nucleotides |
| 08/16/2007 | DE60127731T2 Probiotica zur Verwendung als Futter für Haustiere Probiotics for use as food for pets |
| 08/16/2007 | CA2641638A1 A direct cellular energy delivery system |
| 08/15/2007 | EP1368028B1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation |
| 08/15/2007 | CN101019081A Pharmaceutical compounding systems and methods |
| 08/14/2007 | US7256273 Diagnosis of brain disorders; Alzheimer's disease; genetic engineered immunoglobulins |
| 08/14/2007 | US7256213 Taxanes having a C10 carbonate substituent |
| 08/14/2007 | US7256207 Inhibitors of cathepsin S |
| 08/14/2007 | US7256206 1-[4-(3-Amino-4-hydroxy-3-hydroxymethyl-butyl)-phenyl]-ethanone-O-biphenyl-4-ylmethyl-oxime, used as modulators of lipid activated G-protein coupled receptors specific for sphingosine-1-phosphate; prevention of autoimmune diseases or as angiogenesis inhibitors |
| 08/14/2007 | US7256203 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents |
| 08/14/2007 | US7256200 administering mixture of opioid and calmodulin kinase inhbitor |
| 08/14/2007 | US7255860 Effective against resting pain, mechanically-induced pain and thermally-induced pain without inhibiting wound healing |
| 08/09/2007 | WO2004082612A3 Liposomal formulations and methods of use |
| 08/09/2007 | US20070185350 freeze-drying; microbiocides; for food preparation equipment, sports equipment |
| 08/09/2007 | US20070185214 Process of obtaining type II dehydroquinase enzyme inhibitors and precursors thereof |
| 08/09/2007 | US20070185143 Anticarcinogenic agents, antimetastasis agents; angiogenesis inhibitors; transplant rejection |
| 08/09/2007 | US20070185127 2-(Arylalkoxy)-1-phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors |
| 08/09/2007 | US20070185108 Bicyclo[5.3.1]undecane-based; anticancer agents; alkylation; metathesis cyclization |
| 08/09/2007 | US20070185040 Guanidinium derivatives for improved cellular transport |
| 08/09/2007 | US20070185027 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 08/09/2007 | US20070185018 Use of secretin in treatments of disorders associated with the amygdala |
| 08/09/2007 | US20070184128 Homeopathic formulations useful for treating pain and/or inflammation |
| 08/09/2007 | US20070184120 Adhesin-specific nanoparticles and process for using same |
| 08/09/2007 | US20070184070 Recombinant toxin fragments |
| 08/09/2007 | US20070184067 Alimentary compositions and methods for metabolic modulation |
| 08/08/2007 | EP1687632A4 Plks as modifiers of the beta catenin pathway and methods of use |
| 08/08/2007 | EP1656389B1 A method for cleaving proteins |
| 08/08/2007 | EP1423124B1 Lyophilized formulation comprising olanzapine |
| 08/08/2007 | EP1083914B1 Using ngali nut oil to treat/relieve the pain of arthritis and other similar conditions |
| 08/08/2007 | CN101014358A Biological activity of pigment epithelium-derived factor and methods of use |
| 08/08/2007 | CN101014354A A method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture |
| 08/08/2007 | CN101014349A Antiviral compositions and methods of using the same |
| 08/07/2007 | US7253203 Indoline derivatives |
| 08/07/2007 | US7253170 Pyrazole-amine compounds useful as kinase inhibitors |
| 08/07/2007 | US7253166 6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells |
| 08/07/2007 | US7253164 1,4-benzothiazin-3-one derivatives that are optionally S-mono- or dioxygenated; peptide deformylase inhibitors, used for treating bacterial infections |
| 08/07/2007 | US7253155 Combination of a tetra-substituted pyrimidopyrimidine, and a corticosteroid simultaneously or within 14 days of each other |
| 08/07/2007 | US7252952 In vivo production of cyclic peptides for inhibiting protein—protein interaction |
| 08/07/2007 | CA2365832C Pharmacological screening of neuronally active substances |
| 08/07/2007 | CA2263904C Process to obtain oestrogens from mare's urine |
| 08/02/2007 | WO2004091519A3 Methods of preventing or treating respiratory conditions |
| 08/02/2007 | US20070179192 Thrombopoietin mimetics |
| 08/02/2007 | US20070179184 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/02/2007 | US20070179180 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/02/2007 | US20070179179 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol |
| 08/02/2007 | US20070179171 Vinca derivatives |
| 08/02/2007 | US20070179170 Vinorelbine derivatives |
| 08/02/2007 | US20070179152 Combination therapy for the treatment of neoplasms |
| 08/02/2007 | US20070179132 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/02/2007 | US20070179100 Protected monomers |
| 08/02/2007 | US20070179083 Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding |
| 08/02/2007 | US20070178532 Identification, quantification, and characterization of t cells and t cell antigens |
| 08/02/2007 | US20070178523 Novel druggable regions in set domain proteins, and methods of using the same |
| 08/02/2007 | US20070178438 Apolipoprotein c-1 induced apoptosis |
| 08/02/2007 | US20070178150 Pharmaceutical compositions |
| 08/02/2007 | US20070178132 Injectable chondrocyte implant |
| 08/02/2007 | US20070178081 Combination therapy for treating protein deficiency disorders |
| 08/02/2007 | US20070178079 lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions; lactobacilli, bifidobacteria or Enterococci |
| 08/01/2007 | EP1813312A2 Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent |
| 08/01/2007 | EP1811995A1 A transmucosal veterinary composition comprising detomidine |
| 08/01/2007 | EP1648373A4 Method and device for regulation of limbic system of the brain by means of neuro-electrical coded signals |
| 08/01/2007 | EP1635765A4 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors |
| 08/01/2007 | EP1594442A4 Knockout identification of target-specific sites in peptides |
| 08/01/2007 | EP1540335A4 Screening methods for cognitive enhancers |
| 08/01/2007 | EP1516184B1 Cell-selective delivery system |
| 08/01/2007 | EP1399122B1 Two-phase roll-on cosmetic product |
| 08/01/2007 | EP1133277B1 Pharmaceutical aerosol composition containing hfa 227 and hfa 134a |
| 08/01/2007 | CN1329389C Novel compounds and their use |
| 08/01/2007 | CN101007802A Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 07/31/2007 | US7250419 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 07/31/2007 | US7250412 Diisopropylphenyl esters of N-amino- or N-heterocyclyl-alkanamic acids, e.g., N-(2-Piperidin-1-yl-ethyl)-succinamic acid 2,6-diisopropylphenyl ester; induction and maintenance of anesthesia or sedation |
| 07/31/2007 | US7250165 Anti-TNF antibodies, compositions, methods and uses |
| 07/31/2007 | US7250153 Contrast media formulations having improved biological tolerance |
| 07/31/2007 | CA2343130C Cosmetic composition |
| 07/31/2007 | CA2240705C Cyclosporin-containing soft capsule preparations |
| 07/26/2007 | WO2005041857A3 Bone morphogenetic protein (bmp) 2a and uses thereof |
| 07/26/2007 | WO2004098530A3 Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
| 07/26/2007 | WO2004091515A3 iRNA CONJUGATES |
| 07/26/2007 | US20070173544 Compounds for the treatment of metabolic disorders |
| 07/26/2007 | US20070173479 Methods Using Sulodexide for the Treatment of Bladder Disease |
| 07/26/2007 | US20070173442 Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple schlerosis |
| 07/26/2007 | US20070173441 Inhibitors of n ethymalemide sensitive factor |
| 07/26/2007 | US20070172500 Anthrax antitoxins |
| 07/26/2007 | US20070172446 Synthetic chemokine receptor ligands and methods of use thereof |
| 07/25/2007 | EP1810968A2 9, 10-a, a-OH-texane analogs and methods for production thereof |
| 07/25/2007 | EP1810693A2 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions |
| 07/25/2007 | EP1810680A2 Compositions and methods for use in targeting vascular destruction |
| 07/25/2007 | EP1810679A2 Controlled release oxycodone compositions |
| 07/25/2007 | EP1809307A1 Medical solution, method for producing and use thereof |
| 07/25/2007 | EP1073475B1 Improvements in or relating to diagnostic/therapeutic agents |
| 07/25/2007 | CN101002766A Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors |
| 07/25/2007 | CN101002758A Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 07/24/2007 | US7247654 E.g., N-(2-benzylamino-4-carbamimidoyl-benzyl)-3,5-dimethoxy-4-methyl-benzamide; these compounds inhibit, for example, thrombin, factor Xa, factor XIa, factor IXa, and especially factor VIIa. |
| 07/24/2007 | US7247639 Xanthines 1-substituted with an alkyl group, 3-substituted with a phenylalkylene group and 8-substituted with an arylalkylene group, e.g. 3-[2-[4-(5-aminopentyl-3-amidocarboxypropanoyl)]aminophenyl]ethyl]-8-benzyl-7-[2-ethyl(2-hydroxyethyl)amino]ethyl-1-propylxanthine |
| 07/24/2007 | US7247638 8-Substituted-6,7,8,9-tetrahydropyrimido [1,2-a] pyrimidin-4-one derivatives. |
| 07/24/2007 | US7247633 Pyrimidine compounds and their use |